SCHEMBL20089609

SCHEMBL20089609

C#CCOc1cc(CI)ccc1OC(C)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.44
PTGS2 P35354 1/20 0.42
CFD P00746 1/20 0.41
CYP4F2 P78329 1/20 0.41
CYP4A11 Q02928 1/20 0.41
ALOX5 P09917 5/20 0.40
TSHR P16473 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
RAB9A P51151 1/20 0.39
PDE4B Q07343 1/20 0.38
INSR P06213 1/20 0.38
IGF1R P08069 1/20 0.38
TRPV1 Q8NER1 1/20 0.38
LTA4H P09960 1/20 0.37
HTR2A P28223 1/20 0.37
CYP2B6 P20813 1/20 0.37
CCR5 P51681 1/20 0.36
AKT1 P31749 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19640054 0.87 CYP4F2 (0.56) PTGS1PTGS2CFDCYP4F2CYP4A11
SCHEMBL19640078 0.86 CFD (0.44) PTGS1PTGS2CFDCYP4F2CYP4A11
SCHEMBL19640069 0.78 ALOX5 (0.51) PTGS2ALOX5TSHRKDM4EALDH1A1
SCHEMBL20095342 0.78 PTGS1 (0.57) PTGS1CFDCYP4F2CYP4A11ALOX5
SCHEMBL10508067 0.77 PTGS2 (0.60) PTGS1PTGS2TSHRKDM4EALDH1A1
SCHEMBL19640032 0.76 CYP4F2 (0.49) PTGS1PTGS2CFDCYP4F2CYP4A11
SCHEMBL19640154 0.75 CFD (0.39) PTGS1PTGS2CFDCYP4F2CYP4A11
SCHEMBL19640048 0.74 ALOX15 (0.52) CYP4F2CYP4A11TSHRKDM4EGAA
SCHEMBL19640085 0.73 ALOX15 (0.51) CYP4F2CYP4A11TSHRPDE4BHTR2A
SCHEMBL19655520 0.73 ELANE (0.40) CYP4F2CYP4A11ALDH1A1PDE4BHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11654198-B2 Application of combination of polyethylene glycol and local anesthetic in non-narcotic analgesia JENKEM TECHNOLOGY CO., LTD. (TIANJIN) (CN) 2023-05-23 US disclosed
US-11654198-B2 Application of combination of polyethylene glycol and local anesthetic in non-narcotic analgesia JENKEM TECHNOLOGY CO., LTD. (TIANJIN) (CN) 2023-05-23 US disclosed
US-20200147228-A1 APPLICATION OF COMBINATION OF POLYETHYLENE GLYCOL AND LOCAL ANESTHETIC IN NON-NARCOTIC ANALGESIA JENKEM TECHNOLOGY CO., LTD. (TIANJIN) (CN) 2020-05-14 US disclosed
EP-3315126-A1 CONJUGATE OF POLYETHYLENE GLYCOL AND ANESTHETIC, AND PREPARATION METHOD THEREOF Jenkem Technology Co. Ltd. (Tianjin) (CN) 2018-05-02 EP disclosed
US-20180110867-A1 CONJUGATE OF POLYETHYLENE GLYCOL AND ANESTHETIC, AND PREPARATION METHOD THEREOF JENKEM TECHNOLOGY CO., LTD. (TIANJIN) (CN) 2018-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200147228-A1 APPLICATION OF COMBINATION OF POLYETHYLENE GLYCOL AND LOCAL ANESTHETIC IN NON-NARCOTIC ANALGESIA OPRL1, OPRK1, OPRM1 PTGS1 23/4885PTGS2 31/4885CFD 4676/4885
US-20180110867-A1 CONJUGATE OF POLYETHYLENE GLYCOL AND ANESTHETIC, AND PREPARATION METHOD THEREOF OPRL1, OGFR, F12 PTGS1 248/4885PTGS2 866/4885CFD 3298/4885
US-11654198-B2 Application of combination of polyethylene glycol and local anesthetic in non-narcotic analgesia OPRL1, OPRK1, OPRM1 PTGS1 23/4885PTGS2 31/4885CFD 4676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.